Lilly and Novo Start Measuring Whether GLP-1s Extend Life

16 hours ago 4

Rommie Analytics

Phil Newman, Longevity.Technology

AstraZeneca, Novartis, Novo (formally Novo Nordisk) and Eli Lilly all spoke from the platform at this year's ARDD at Harvard. Novo and Lilly each showed...

Read Entire Article